Alzheimer’s Society NICE challenge submitted to high court
Published 27 April 2007
Serious flaws in the way the NICE reached its controversial decision to restrict access to dementia drugs on the NHS will be submitted to the high court today by the Alzheimer’s Society.
The dossier of evidence highlights the way NICE drastically underestimated costs of care, overlooked benefits of drugs to carers and ignored the way the decision will grossly discriminate against people of different cultural and educational backgrounds.
The staggering submission is the first stage of a lengthy legal appeal that will challenge NICE in the high court for the first time. Campaigners are now awaiting a court date for arguments to be heard.
Neil Hunt, chief executive of the Alzheimer's Society, says,
'The evidence we are presenting today highlights serious flaws in the process NICE have used. The decision is a blow for millions of people already devastated by Alzheimer's disease. We have been left with no choice but to champion the rights of people with dementia and their carers in the high court.'
